Discontinued — last reported Q2 '21
Non-Current Liabilities
Unrecognized Tax Benefits
West Pharmaceutical Services Unrecognized Tax Benefits increased by 15.3% to $64.70M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ3 2015
Last reportedQ2 2021
How to read this metric
A decrease generally signals the resolution of tax audits or the expiration of statutes of limitations, while an increase suggests new tax planning risks.
Detailed definition
This represents the cumulative amount of tax benefits from uncertain tax positions that have not been recognized in the...
Peer comparison
Standard for multinational corporations; peers with complex global tax structures often carry significant balances in this category.
Metric ID:
unrecognized_tax_benefitsHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $56.10M | $64.70M |
| QoQ Change | — | +15.3% |
Range$56.10M – $64.70M
Unrecognized Tax Benefits at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's unrecognized tax benefits?
- West Pharmaceutical Services (WST) reported unrecognized tax benefits of $64.70M in Q1 2026.
- What does unrecognized tax benefits mean?
- The amount of potential tax savings that the company has not yet claimed because the outcome is uncertain.